ARCHIVES

FDA Moves To Revoke Avastin’s Breast Cancer Accelerated Approval, Genentech Vows To Fight

This article is from The Cancer Letter archive.

Vol. 36 No. 46 | December 17, 2010

Download PDF Visit The Full Archive

Related Articles

New Technology May Enable Therapy Tailored To Patient’s Predicted Response

April 26, 2002

Pertuzumab Delays Progression In HER2-Positive Breast Cancer

August 26, 2011

ECOG, ACRIN Agree To Join; NCI’s Goal Of Four Adult Groups Is One Merger Away

March 18, 2011

NCI-Approved Clinical Trials

November 24, 2006

Group Chairmen Accept Most Changes In Terms Of Award, Object To CTEP Adjustments

December 2, 1988

Patient Advocacy: congress Delivers Symbolism, Not Solution, Visco Says

October 17, 1997